Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
12/2010
12/21/2010US7855294 (6R,8S)-6-(spiro[isobenzofuran-1-(3H), 4'-piperidin]-1'-ylmethyl)-5,6,7,8-tetrahydroquinolin-8-ol), exhibiting an antagonism to binding of nociceptin to opioid receptor-like-1 receptors, useful as medicines for diseases associated with pain and appetite control or memory and learning
12/21/2010US7855291 Process for the preparation of substituted phenylalanines
12/21/2010US7855290 Pyridine derivatives and pyrimidine derivatives (3)
12/21/2010US7855215 such as 6-(6-Amino-pyrimidin-4-yloxy)-3,4-dihydro-2H-quinoline-1-carboxylic acid (3-trifluoromethyl-phenyl)-amide, used for the treatment of leukemia
12/21/2010US7855212 Pyridinyl acetonitriles
12/21/2010CA2426654C 2,4,8-trisubstituted-8h-pyrido[2,3-d}pyrimidin-7-one compounds
12/21/2010CA2423351C Novel arylalkane-sulfonamides
12/21/2010CA2408596C New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound
12/21/2010CA2404594C Agent for prophylaxis and treatment of renal disease
12/16/2010WO2010142766A2 Pyrimidine derivatives as zap-70 inhibitors
12/16/2010WO2010142656A1 Heterocyclic antiviral compounds
12/16/2010WO2010142027A1 Guanine riboswitch binding compounds and their use as antibiotics
12/16/2010WO2010116088A3 Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof
12/16/2010WO2010083241A3 2,4-pyrimidinediamine compounds for treatment of inflammatory disorders
12/16/2010US20100317855 Process for the preparation of substantially pure (2s,3s,5s)-5-amino-2-n,n-dibenzylamino-3-hydroxy-1,6-diphenylhexane
12/16/2010US20100317854 Novel aminodicarboxylic acid derivatives having pharmaceutical properties
12/16/2010US20100317643 Janus kinase inhibitor compounds and methods
12/16/2010US20100317607 Use of compounds for preparing anti-tuberculosis agents
12/16/2010US20100317524 Sulfonylureas
12/16/2010CA2778931A1 Guanine riboswitch binding compounds and their use as antibiotics
12/16/2010CA2765053A1 Isoquinoline, quinoline, and quinazoline derivatives as inhibitors of hedgehog signaling
12/16/2010CA2764141A1 Heterocyclic antiviral compounds
12/16/2010CA2763717A1 Pyrimidine derivatives as zap-70 inhibitors
12/15/2010EP2261225A1 Heterocyclic compounds and their use as aldosterone synthase inhibitors
12/15/2010EP2260026A1 Quinazolinone derivatives as tubulin polymerization inhibitors
12/15/2010EP1634883B1 2-substituted phenyl-5,7-dialkyl-3,7-dihydropyrrole[2,3-d] pyrimidine-4-one derivatives, the preparation and the pharmaceutical use thereof
12/15/2010CN1984660B 4-arylamino-quinazolines as activators of aspartic acid specificity cysteine protease and inducers of apoptosis
12/15/2010CN1916009B Process for preparing amine platinum complexes
12/15/2010CN1909909B 1-benzyl-5-piperazin-1-yl-3,4-dihydro-1H- quinazolin-2-one derivatives and the respective 1H-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzene as modulators of the 5-hydroxytryptamine recept
12/15/2010CN101918374A 6.7-dialkoxy ouinazoline derivatives useful for treatment of cancer related disorders
12/15/2010CN101918373A Pyrimidyl cyclopentanes as akt protein kinase inhibitors
12/15/2010CN101918372A Process for preparing N-substituted hydroxypyrimidinone carboxamides
12/15/2010CN101918371A Amide derivatives as sirtuin modulators
12/15/2010CN101918370A Compound for organic electroluminescent device and organic electroluminescent device using the same
12/15/2010CN101918369A N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (HCV) inhibitors
12/15/2010CN101917981A Peptide deformylase inhibitors
12/15/2010CN101914068A Novel crystal form of erlotinib alkali and preparation method thereof
12/15/2010CN101914067A Method for synthesizing N-methyl pyrimidone
12/15/2010CN101914066A Method for purifying and detecting pirimicarb by utilizing molecularly imprinted polymer (MIP)
12/15/2010CN101914065A Pyrimidinylacetic acid derivatives useful for the treatment of diseases mediated by crth2
12/15/2010CN101914042A Preparation method of nicarbazin midbody 4,4'- binitro sym-diphenylurea
12/15/2010CN101357904B 2-phenyl-4,6-dichloro pyrimidine preparation method
12/15/2010CN101353328B Preparation of 2-chlorin-4-amido-6,7-dimethoxy quinazoline
12/15/2010CN101230015B Substituted cinnamic acid derivatives containing amine substituent group and tumor cytotoxicity thereof
12/15/2010CN101200451B Method for preparing hydrochloride urapidil
12/15/2010CN101171238B (3,4-dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amines having an activity on the 5-HT receptor
12/14/2010US7851624 Purity; oxidation of the corresponding diol compound using a borane in solvent; hydrolysis
12/14/2010US7851623 Chemical process
12/14/2010US7851469 Isoxazole-imidazole derivatives
12/14/2010US7851463 such as Parkinson's disease, schizophrenia, cognitive disorders, depression, anxiety, drug addiction, eating disorders and urogenital disorders; 4-(2,2-Difluoro-cyclopropyl)-N-[4-(1-propyl-piperidin-3-yl)-phenyl]-benzenesulfonamide
12/14/2010CA2437944C Acylated indanyl amines and their use as pharmaceuticals
12/09/2010WO2010140802A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
12/09/2010WO2010140765A2 Novel method for preparing rosuvastatin, intermediate compounds useful for preparing same, and method for preparing same
12/09/2010WO2010139271A1 E-type phenyl acrylic ester compounds containing substituted anilino pyrimidine group and uses thereof
12/09/2010WO2010139180A1 Naphthalene carboxamide derivatives as inhibitors of protein kinase and histone deacetylase, preparation methods and uses thereof
12/09/2010US20100311965 2-aminoquinazoline derivative
12/09/2010US20100311769 Novel quinazoline-2,4-dione derivative, and medical compositions for the prophylaxis and treatment of cranial nerve disease containing the same
12/09/2010US20100311175 Mass tags for quantitative analyses
12/09/2010US20100309402 Four- or five-ring liquid crystal compound having lateral fluorine, liquid crystal composition, and liquid crystal display device
12/09/2010CA2763822A1 Naphthalene carboxamide derivatives as inhibitors of protein kinase and histone deacetylase, preparation methods and uses thereof
12/08/2010EP2259068A2 Capture compounds and methods for analyzing the proteome
12/08/2010EP2258689A1 Benzylated PDE4 inhibitors
12/08/2010EP2258366A2 Quinoline derivatives and quinazoline derivatives capable of inhibiting autophosphorylation of hepatocyte growth factor receptors, and pharmaceutical composition comprising the same
12/08/2010CN101906076A Naphthaline amide derivative serving as protein kinase inhibitor and histone deacetylase inhibitor and preparation method and application thereof
12/08/2010CN101906075A E-type phenyl acrylic acid ester compound containing substituted anilino pyrimidine group and applications thereof
12/08/2010CN101906053A 酰胺衍生物 Amide derivatives
12/08/2010CN101463015B Preparation of 5,6,7-trialkoxy-N-aryl substituted-4-amino quinazoline derivative and compound synthesized thereby
12/08/2010CN101391984B Method for carrying out methylation to pyrimidine heterocyclic compound containing sulfhydryl by dimethyl carbonate
12/08/2010CN101376647B Method for synthesizing rosuvastatin intermediate and rosuvastatin
12/08/2010CN101208309B Chloro-substituted guanidines
12/08/2010CN101208308B 8-alk0xy-4-methyl-3, 4-dihydr0-quinaz0lin-2-yl amines and their use as 5-HT5A receptor ligands
12/07/2010US7847097 alkylating 3-phenyluracils; phase transfer catalysts; herbicides, agriculture
12/07/2010US7846922 1-(isopropyl)-4-{[4-(tetrahydro-2H-pyran4-yloxy)phenyl]carbonyl}hexahydro-1H-1,4-diazepine, used in the treatment of nervous system and psychological disorders such as Alzheimer's disease or as cognition activators
12/07/2010US7846514 a halogeno-benzene derivative having a trifluoropropenyl group or trifluoropropynyl group at a side chain, such as, for example, trans-4'-[3,5-difluoro-4-(3,3,3-trifluoropropenyl)phenyl]-trans-4-propylbicyclohexyl; stability to heat and light
12/07/2010US7846469 Reversible inhibition of sperm receptor synthesis for contraception
12/07/2010CA2471883C Phenylpyrimidine amines as ige inhibitors
12/07/2010CA2458360C Detection of transmembrane potentials by optical methods
12/07/2010CA2374995C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
12/07/2010CA2299632C Substituted quinazoline derivatives and their use as tyrosine kinase inhibitors
12/02/2010WO2010138828A2 Potassium channel modulators
12/02/2010WO2010137517A1 Triallylisocyanurate, triallylcyanurate, and process for production of triallylisocyanurate
12/02/2010WO2010137336A1 NOVEL α-PHENOXYBENZENEACETIC ACID DERIVATIVE AND PHARMACEUTICAL PREPARATION COMPRISING SAME
12/02/2010WO2010137160A1 Prophylactic or therapeutic agent for pulmonary fibrosis
12/02/2010WO2010136804A1 Pyrimidine derivatives for use as antibiotics
12/02/2010WO2010136559A1 2, 4 -diaminopyrimidines for the treatment of diseases characterised by excessive or abnormal cell proliferation
12/02/2010WO2010136493A1 Substituted aminopropionic derivatives as neprilysin inhibitors
12/02/2010WO2010059838A3 Pde4 inhibitors selective for the long form of pde4 for treating inflammation and avoiding side effects
12/02/2010US20100305321 Process for chiral resolution of 2-substituted 4-substituted 1,3-oxathiolanes
12/02/2010US20100305320 Polymorph, polymorph screening system, and polymorph preparing and screening method
12/02/2010US20100305131 Substituted Aminopropionic Derivatives as Neprilysin inhibitors
12/02/2010US20100305109 Potassium channel modulators
12/02/2010US20100305100 Methods for treating hepatitis c
12/02/2010US20100305099 Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation
12/02/2010US20100305078 Metallo-oxidoreductase inhibitors using metal binding moieties in combination with targeting moieties
12/02/2010CA2763700A1 2, 4-diamino pyrimidines for the treatment of diseases characterised by excessive or abnormal cell proliferation
12/02/2010CA2763572A1 Substituted aminopropionic derivatives as neprilysin inhibitors
12/01/2010EP2254415A1 Aryl-hydroxyethylamino-pyrimidines and triazines as modulators of fatty acid amide hydrolase
12/01/2010CN101903357A Cyclic amine substituted pyrimidinediamines as PKC inhibitors
12/01/2010CN101903356A 4-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereof
12/01/2010CN101903351A 病毒聚合酶抑制剂 Viral polymerase inhibitors
1 ... 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 ... 427